期刊文献+

香菇多糖注射液联合FOLFOX方案治疗晚期结肠癌的效果观察 被引量:5

Effect of Lentinan Injection Combined FOLFOX for Advanced Colon Cancer
下载PDF
导出
摘要 目的探讨香菇多糖注射液联合FOLFOX方案治疗晚期结肠癌的临床疗效。方法将90例晚期结肠癌患者按照住院时间先后顺序分组为对照组和治疗组。对照组:采用亚叶酸钙,200 mg/m2,静脉滴入,1次/天;奥沙利铂,100 mg/m2,静脉滴入,1次/天;5-氟尿嘧啶,400 mg/m2,静脉滴注,1次/天;5-氟尿嘧啶,600 mg/m2,持续静脉泵入22 h,d1-2。治疗组:在对照组治疗基础上,同时给患者采用香菇多糖注射液1 mg,2次/周,静脉滴注。观察2组患者的近、远期疗效和不良反应及对细胞因子的影响。结果治疗后,治疗组1、2、3年生存率分别为75.56%(34/45)、55.56%(25/45)、37.78%(17/45),与对照组71.11%(32/45)、35.56%(16/45)、24.44%(11/45)比较,1年生存率差异无统计学意义(P>0.05),2、3年生存率差异有统计学意义(P<0.05)。此外,2组患者近期临床疗效和不良反应比较,P均<0.05。2组患者治疗后血清IL-2和TNF-α及IFN-γ水平与治疗前比较,均出现明显上升,但治疗组升高较为显著(P<0.05)。结论相比FOLFOX方案化疗来说,采用香菇多糖注射液联合FOLFOX方案治疗晚期结肠癌,能提高患者近、远期疗效,且不良反应少,同时还能有效改善患者免疫功能,提高患者抵抗力。 Objective To explore the clinical curative effect of lentinan injection combined FOLFOX for advanced colorectal cancer. Methods 90 cases of patients with advanced colon cancer were divided into the control group and the treatment group. Control group received calcium leucovorin,200 mg / m2,intravenous drip,once/d; Oxaliplatin,100 mg/m2,intravenous drip,once / d; 5-fluorouracil,400 mg / m2,the intravenous drip,once/d; 5-fluorouracil,600 mg/m2,continuous intravenous pumping22 h and d1-2. Treatment group received additional lentinan injection 1 mg,twice / week,intravenous drip on the basis of the control treatment. The short-term and long-term curative effects,adverse reaction and the influence of cytokines of the 2 groups were observed. Results After treatment,1-,2-,3-year survival rates of the treatment group were 75. 56%( 34 /45),55. 56%( 25 /45),37. 78%( 17 /45),and those of the control group were 71. 11%( 32 /45),35. 56%( 16 /45),24. 44%( 11 /45),there was no statistically significant difference in 1-year survival rate( P > 0. 05),2-,3-year survival rate had statistically significant difference( P < 0. 05). In addition,recent clinical curative effect and adverse reactions of the 2 groups had statistically significant difference,P < 0. 05. Serum IL-2,TNF alpha and IFN-gamma levels of the 2 groups after treatment had statistically significant difference,and treatment group had higher increase( P < 0. 05). Conclusion Compared with FOLFOX schemes,lentinan injection combined with FOLFOX regimen for advanced colon cancer can improve short-term and long-term curative effects,with less adverse reactions,and it can effectively improve the patients’ immune function and resistance.
作者 董霞 李欠欠
出处 《实用癌症杂志》 2015年第1期136-138,共3页 The Practical Journal of Cancer
关键词 香菇多糖注射液 晚期结肠癌 FOLFOX方案化疗 免疫功能 Lentinan injection Advanced colorectal cancer FOLFOX chemotherapy Immunologic function
  • 相关文献

参考文献10

二级参考文献63

  • 1Zhou, Yuan,Ling, Xian-Long,Li, Shi-Wei,Li, Xin-Qiang,Yan, Bin.Establishment of a human hepatoma multidrug resistant cell line in vitro[J].World Journal of Gastroenterology,2010,16(18):2291-2297. 被引量:17
  • 2庞志东,李文锋,刘剑勇,周任.DC联合香菇多糖激活TIL体外抗小鼠肝癌研究[J].广西医科大学学报,2009,26(6):909-911. 被引量:3
  • 3王峻,周智东,夏大静.香菇多糖增强树突状细胞瘤苗的抗肿瘤作用及其机制研究[J].中国中西医结合杂志,2007,27(1):60-64. 被引量:29
  • 4李鼎九,胡自省,钟毓斌.肿瘤热疗学[M].郑州:郑州大学出版社,2001,392-395.
  • 5Andre T,Boni C,Mounedji-Boudiaf L,et al.Oxaliplatin,fluorouracil,and leucovorin as adjuvant treatment for colon cancer[J].N Engl J Med,2004,350:2343-2351.
  • 6Van Cutsem,Nordlinger B,Adam R et al.Towards a pan-European consensus on the treatment of patients with colorectal liver metastases[J].Eur J Cancer,2006,42,2212-2221.
  • 7Milani V,Pazos M,Issels RD,et al.Radiochemotherapy in combination with regional hyperthermia in preirradiated patients with recurrent rectal cancer[J].Strahlenther Onkol,2008,184(3):163-168.
  • 8Atanackovic D,Nierhaus A,Neumeier M,et al.41.8 ℃ whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases[J].Cancer Immunol Immunother,2002,51(11-12):603-613.
  • 9Yoo J,Kim HR,Lee YJ.Hyperthermia enhances tumour necrosis factor-related apoptosis-inducing ligand(TRAIL)-induced apoptosis in human cancer cells[J].Int J Hyperthermia,2006,22(8):713-728.
  • 10Sakamoto J, Clin K, Kondo K, et al. Phase I1 study of a 4-week capecitabine regimen in advanced or recurrent gastric cancer [J].Anticancer Drugs,2006;17 (2): 231-6.

共引文献110

同被引文献98

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部